la Fougere C, Rominger A, Forster S, Geisler J, Bartenstein P. PET and SPECT in epilepsy: a critical review. Epilepsy Behav. 2009;15:50-5 pubmed publisher
..Currently some of these radioligands are also used to investigate new treatment approaches. ..
la Fougere C, Popperl G, Levin J, Wängler B, Böning G, Uebleis C, et al. The value of the dopamine D2/3 receptor ligand 18F-desmethoxyfallypride for the differentiation of idiopathic and nonidiopathic parkinsonian syndromes. J Nucl Med. 2010;51:581-7 pubmed publisher
..The PET procedure for this differential diagnosis was superior to the reported experience with (123)I-iodobenzamide SPECT. ..
la Fougere C, Grant S, Kostikov A, Schirrmacher R, Gravel P, Schipper H, et al. Where in-vivo imaging meets cytoarchitectonics: the relationship between cortical thickness and neuronal density measured with high-resolution [18F]flumazenil-PET. Neuroimage. 2011;56:951-60 pubmed publisher